Sun Pharmaceuticals Deal History & Licensing Activity
Sun Pharmaceuticals is a large biotech headquartered in US. Over the past three years, Sun Pharmaceuticals has been involved in 3 licensing and acquisition transactions, with a primary focus on Other (6 deals). The company currently has 5 active clinical trials, primarily in Women's Health.
Deals (12mo)
2
Active Trials
5
Top Modality
Other
Focus Area
Women's Health
Sun Pharmaceuticals Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Sun Pharmaceuticals in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Organon | Organon | Other | Approved | acquisition | May 15, 2026 |
| Sun Pharmaceuticals | Organon | Other | Unknown | acquisition | May 15, 2026 |
| Organon (company acquisition) | Organon | Other | Approved | acquisition |
Sun Pharmaceuticals Pipeline Focus
Therapeutic areas and modalities where Sun Pharmaceuticals is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Sun Pharmaceuticals Strategic Signals
Key indicators of Sun Pharmaceuticals's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Sun Pharmaceuticals Clinical Pipeline
Sun Pharmaceuticals has 5 active clinical trials across 2 development phases.
1
Phase 2
4
Phase 3
See How Your Asset Matches Sun Pharmaceuticals's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Women's Health assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Women's Health Deal Benchmarks
Market sizing, deal terms, and competitive landscape for women's health
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Sun Pharmaceuticals Licensing & Deal Activity
Sun Pharmaceuticals is a large biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 3 deals over the past three years, Sun Pharmaceuticals ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Sun Pharmaceuticals include Women's Health (4 deals and trials), Solid Tumors (3 deals and trials), Other (2 deals and trials), and CNS Disorders (1 deal and trial). In terms of modality, Sun Pharmaceuticals has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Sun Pharmaceuticals and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Sun Pharmaceuticals's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.